Article info
PDFABN abstracts
Abstracts from the Association of British Neurologists Annual Meeting 2011
168 Rituximab in the treatment of Multifocal Acquired Demyelinating Sensory and Motor Neuropathy (MADSAM)
Citation
168 Rituximab in the treatment of Multifocal Acquired Demyelinating Sensory and Motor Neuropathy (MADSAM)
Publication history
- First published February 9, 2012.
Online issue publication
February 25, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.